|
- Launch of new PAS-X product versions: PAS-X PHARMA Version 2.3 and PAS-X BIOTECH Version 2.2 are released
- Independent analysts rank Werum's MES market share in the pharmaceutical and biotechnical industries among the top 3 - at the same level with two of its competitors
|
|
|
- Aiming at the global harmonization of future MES installations, Merck & Co. decides in favor of the product suite PAS-X
- One of the worldwide largest biotech companies chooses
PAS-X BIOTECH
- Werum introduces PAS-X CT for clinical trials manufacturing and PAS-CAPA for deviation and complaint management
|
|
|
- Werum launches PAS-X PHARMA Version 2.2
- The largest cell culture plant in Europe, Boehringer Ingelheim in Biberach, Germany, goes into production with PAS-X BIOTECH
|
|
|
- MES for LIFE (Leading Infusion Factory Europe), B. Braun
- A Japanese PAS-X version is available
- The PAS-X User Forum is founded
- The product PAS-X BIOTECH is introduced
|
|
|
- Novartis Suffern, one of the largest and most comprehensive MES projects
in the USA, goes into operation; start of the global roll-out for PAS-X at Novartis
|
|
|
- Global agreement with Akzo Nobel Organon
- "Easy to Operate" PAS-X PHARMA Version 2.1
|
|
|
- Global Agreement with Novartis
- Werum Software & Systems America, Inc. is founded
|
|
|
- Werum establishes itself as one of the leading MES suppliers
for Europe's pharmaceutical industry
|
|
|
- Implementation of the first comprehensive PAS-X version
under FDA validation
|
|
|
- First projects in validated environments
|
|
|
- Standard products for pharmaceutical industry, marketed by:
|
|
|
- First PAS-X version for the pharmaceutical industry
|
|